Alembic Group Stocks

List of Alembic Group Stocks in India 2025

Alembic Group stocks represent shares of companies under the Alembic Group umbrella, a prominent business conglomerate in India. With a rich history spanning over a century, the group is involved in diverse sectors such as pharmaceuticals, chemicals, and more. This article explores the Alembic Group stock list, its history, sector presence, and key personnel, providing a comprehensive guide for potential investors.

The Alembic Group operates several publicly listed companies, each contributing significantly to its diversified portfolio. Below is a table of Alembic Group stocks, including their company names and ticker symbols:

Note: Market capitalisation figures are indicative and subject to change based on market trends.

Alembic Pharmaceuticals is a leading player in the pharmaceutical industry, while Paushak Limited is involved in the manufacturing of speciality chemicals. Both companies are integral to the Alembic Group’s success and are key considerations for investors.

The Alembic Group was established in 1907, making it one of India’s oldest business conglomerates. It began as a small pharmaceutical company in Vadodara, Gujarat, focusing on the production of tinctures and alcohol-based products. Over the decades, the group expanded its operations, diversifying into multiple sectors such as chemicals, glass, and real estate.

Key milestones in the group’s history include:

• 1940s: Diversification into bulk drugs and intermediates.
• 1980s: Establishment of Alembic Pharmaceuticals as a separate entity.
• 2000s: Expansion into specialty chemicals through Paushak Limited.

Today, the Alembic Group is recognised for its innovation, sustainability, and contributions to India’s industrial growth.

The Alembic Group operates in a variety of industries, showcasing its diversified business model. Below are the primary sectors in which the group has a significant presence:

• Pharmaceuticals: Alembic Pharmaceuticals is a market leader in the production of generic drugs, active pharmaceutical ingredients (APIs), and formulations.
• Specialty Chemicals: Paushak Limited focuses on the manufacturing of advanced intermediates and specialty chemicals used in various industries.
• Real Estate: The group has ventured into real estate development through Shreno Limited, catering to the residential and commercial property markets.

This multi-sector presence not only strengthens the group’s portfolio but also mitigates risks associated with market fluctuations in individual industries.

The Alembic Group’s success can be attributed to its visionary leadership and dedicated workforce. Below are some of the key personnel driving the group’s growth:

• Mr. Chirayu Amin: Chairman of Alembic Pharmaceuticals, he has been instrumental in steering the group’s expansion and innovation over the years.
• Mr. Pranav Amin: Co-Chairman and Managing Director of Alembic Pharmaceuticals, he oversees the company’s strategic initiatives and global operations.
• Mr. Shaunak Amin: Managing Director of Alembic Pharmaceuticals, he focuses on the domestic market and operational excellence.

The leadership team’s commitment to innovation and sustainability has helped the Alembic Group maintain its competitive edge in the market.

Alembic Group stocks, including Alembic Pharmaceuticals and Paushak Limited, represent investment opportunities in well-established companies with a proven track record. The group’s diversified sector presence and strong leadership further enhance its appeal to investors. However, as with any investment, it is essential to conduct thorough research and consult financial advisors before making decisions.

Investments in securities markets are subject to market risks. Please read all scheme-related documents carefully before investing.
Past performance is not indicative of future returns.